Skip to content
10-Q

Quarterly Report

BICARA THERAPEUTICS INC. BCAX

0002023658-25-000109

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 54.78M sh
Shares Diluted Q3 2025 · Sep 30, 2025 54.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 54.52M sh
Shares Diluted Q3 2025 · Sep 30, 2024 10.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.17M sh
Capex Q3 2025 · Sep 30, 2025 $42K
Capex Q3 2025 · Sep 30, 2024 $31K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$82.95M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$44.72M
Short Term Investments Q3 2025 · Sep 30, 2025 $118.49M
Short Term Investments Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $171.67M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $489.71M
Stockholders Equity Q3 2025 · Sep 30, 2025 $402.78M
Stockholders Equity Q3 2025 · Jun 30, 2025 $435.2M
Stockholders Equity Q3 2025 · Mar 31, 2025 $458.96M
Stockholders Equity Q3 2025 · Dec 31, 2024 $491.88M
Stockholders Equity Q3 2025 · Sep 30, 2024 $509.56M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$174.78M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$160.08M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$148.77M
Current Liabilities Q3 2025 · Sep 30, 2025 $21.03M
Current Liabilities Q3 2025 · Dec 31, 2024 $17.99M
Total Liabilities Q3 2025 · Sep 30, 2025 $21.91M
Total Liabilities Q3 2025 · Dec 31, 2024 $18.12M
Current Assets Q3 2025 · Sep 30, 2025 $297.37M
Current Assets Q3 2025 · Dec 31, 2024 $502.53M
Total Assets Q3 2025 · Sep 30, 2025 $424.69M
Total Assets Q3 2025 · Dec 31, 2024 $510M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.67
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.84
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.60
Eps Diluted Q3 2025 · Sep 30, 2024 −$11.27
Eps Basic Q3 2025 · Sep 30, 2025 −$0.67
Eps Basic Q3 2025 · Sep 30, 2025 −$1.84
Eps Basic Q3 2025 · Sep 30, 2024 −$1.60
Eps Basic Q3 2025 · Sep 30, 2024 −$11.27
Sga Expense Q3 2025 · Sep 30, 2025 $7.7M
Sga Expense Q3 2025 · Sep 30, 2025 $22.38M
Sga Expense Q3 2025 · Sep 30, 2024 $4.76M
Sga Expense Q3 2025 · Sep 30, 2024 $12.02M
Rd Expense Q3 2025 · Sep 30, 2025 $33M
Rd Expense Q3 2025 · Sep 30, 2025 $92.1M
Rd Expense Q3 2025 · Sep 30, 2024 $15.9M
Rd Expense Q3 2025 · Sep 30, 2024 $43.7M
Net Income Q3 2025 · Sep 30, 2025 −$36.33M
Net Income Q3 2025 · Sep 30, 2025 −$100.56M
Net Income Q3 2025 · Jun 30, 2025 −$27.39M
Net Income Q3 2025 · Mar 31, 2025 −$36.85M
Net Income Q3 2025 · Sep 30, 2024 −$17.48M
Net Income Q3 2025 · Sep 30, 2024 −$47.04M
Net Income Q3 2025 · Jun 30, 2024 −$17.05M
Net Income Q3 2025 · Mar 31, 2024 −$12.51M
Operating Income Q3 2025 · Sep 30, 2025 −$40.68M
Operating Income Q3 2025 · Sep 30, 2025 −$114.48M
Operating Income Q3 2025 · Sep 30, 2024 −$20.63M
Operating Income Q3 2025 · Sep 30, 2024 −$55.75M